June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...
Neither first- nor second-generation antipsychotics show a clear benefit over placebo for preventing or treating delirium in hospitalized adults, and their routine use should be discontinued, ...
Antipsychotic medicines are a key part of the pharmacological treatment of schizophrenia. Although they provide therapeutic ...
Hosted on MSN
Schizophrenia Medication Types and Effects
Schizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as second-generation or "atypical" antipsychotics ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
A new study analyzing Medicaid databases from 2017 to 2021 has uncovered significant differences in how long-acting injectable (LAI) antipsychotic medications are prescribed to older adults across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results